Autolus Therapeutics (AUTL)
1.74
0.01 (0.58%)
At close: Mar 03, 2025, 3:59 PM
1.75
0.86%
After-hours: Mar 03, 2025, 04:00 PM EST
Autolus Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Cash & Equivalents | 239.57M | 382.44M | 310.34M | 153.3M | 210.64M | 189.3M | 137.07M | 28.06M | 10.18M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 1.36M | 4.01M | 4.4M | 5.66M | 2.04M | n/a | n/a | -9.5M | n/a |
| Receivables | 1.05M | 153K | 68K | 29.68M | 30.52M | 9.26M | 4.73M | 2.18M | n/a |
| Inventory | n/a | 14.16M | 10.12M | -29.68M | 7.81M | 2.21M | n/a | n/a | n/a |
| Other Current Assets | 34.69M | 43.18M | 36.55M | 14M | 8.09M | 2.92M | 681K | 688K | 1.31M |
| Total Current Assets | 275.3M | 425.77M | 346.95M | 196.98M | 249.26M | 199.14M | 142.48M | 30.93M | 11.49M |
| Property-Plant & Equipment | 95.65M | 58.42M | 52.32M | 89.68M | 51.57M | 9.22M | 6.18M | 3.25M | 915.95K |
| Goodwill & Intangibles | n/a | n/a | 65K | 158K | 254K | 9.29M | n/a | 9.5M | 10.24M |
| Total Long-Term Assets | 100.08M | 64.5M | 58.61M | 97.25M | 54.28M | 18.51M | 6.18M | 3.25M | 11.16M |
| Total Assets | 375.38M | 490.27M | 405.56M | 294.24M | 303.53M | 217.66M | 148.66M | 34.18M | 22.66M |
| Account Payables | 103K | 531K | 431K | 2.26M | 1.07M | 3.04M | 1.95M | 1.44M | 1.69M |
| Deferred Revenue | n/a | n/a | 23.52M | 27.29M | 20.68M | 569K | 197K | 53K | n/a |
| Short-Term Debt | 5.05M | 10.08M | 4.45M | 7.18M | 5.02M | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 39.58M | 35.76M | 23.67M | 24.19M | 18.5M | 13.53M | 2.89M | 1.3M | 259.41K |
| Total Current Liabilities | 44.74M | 46.37M | 28.55M | 33.63M | 24.98M | 12.52M | 5.03M | 2.73M | 1.95M |
| Long-Term Debt | 47.91M | 19.22M | 16.55M | 50.57M | 23.71M | 442K | 265K | 188K | n/a |
| Other Long-Term Liabilities | 171.26M | 126.02M | 47.14M | n/a | n/a | 159K | 763K | 570K | n/a |
| Total Long-Term Liabilities | 219.17M | 145.23M | 63.69M | 50.57M | 23.71M | 601K | 1.03M | 758K | n/a |
| Total Liabilities | 263.91M | 191.6M | 92.24M | 84.2M | 48.69M | 12.52M | 6.06M | 3.49M | 1.95M |
| Total Debt | 52.97M | 24.26M | 21M | 54.16M | 26.22M | 221K | 265K | 188K | n/a |
| Common Stock | 8K | 8K | 4K | 3K | 2K | 1.28K | 1K | 577.00 | 322.31 |
| Retained Earnings | -878.56M | -670.18M | -521.34M | -379.24M | -237.15M | 163.84M | -47.9M | -28.18M | -9.33M |
| Comprehensive Income | -28.99M | -38.9M | -8.57M | -5.86M | -8.69M | -76.27M | -3.85M | -4.65M | -0.00 |
| Shareholders Equity | 111.47M | 298.67M | 313.32M | 210.03M | 254.84M | 205.14M | 142.6M | 30.69M | 20.71M |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |